This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Centogene Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Centogene's earnings have been declining at an average annual rate of -18%, while the Healthcare industry saw earnings declining at 0.8% annually. Revenues have been growing at an average rate of 0.8% per year.
Belangrijke informatie
-18.0%
Groei van de winst
-9.8%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 15.7% |
| Inkomstengroei | 0.8% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -73.2% |
| Laatste winstupdate | 31 Dec 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Centogene geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 23 | 49 | -36 | 46 | 12 |
| 30 Sep 23 | 50 | -38 | 45 | 14 |
| 30 Jun 23 | 51 | -40 | 45 | 15 |
| 31 Mar 23 | 49 | -40 | 44 | 16 |
| 31 Dec 22 | 47 | -39 | 42 | 17 |
| 30 Sep 22 | -15 | -44 | 46 | 20 |
| 30 Jun 22 | 2 | -58 | 49 | 20 |
| 31 Mar 22 | 190 | -44 | 55 | 20 |
| 31 Dec 21 | 42 | -57 | 54 | 19 |
| 30 Sep 21 | 162 | -40 | 59 | 17 |
| 30 Jun 21 | 168 | -24 | 57 | 18 |
| 31 Mar 21 | 126 | -27 | 55 | 17 |
| 01 Jan 21 | 38 | -60 | 49 | 15 |
| 30 Sep 20 | 73 | -30 | 43 | 14 |
| 30 Jun 20 | 49 | -28 | 39 | 11 |
| 31 Mar 20 | 50 | -24 | 35 | 11 |
| 31 Dec 19 | 49 | -21 | 33 | 10 |
| 30 Sep 19 | 44 | -19 | 30 | 9 |
| 30 Jun 19 | 45 | -16 | 30 | 8 |
| 31 Mar 19 | 43 | -13 | 28 | 7 |
| 31 Dec 18 | 40 | -11 | 26 | 6 |
| 30 Sep 18 | 39 | -9 | 23 | 7 |
| 31 Dec 17 | 32 | -5 | 15 | 6 |
| 31 Dec 16 | 28 | -5 | 14 | 6 |
Kwaliteitswinsten: 39K is currently unprofitable.
Groeiende winstmarge: 39K is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 39K is unprofitable, and losses have increased over the past 5 years at a rate of 18% per year.
Versnelling van de groei: Unable to compare 39K's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: 39K is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.2%).
Rendement op eigen vermogen
Hoge ROE: 39K's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.